Quick Answer
Adaptive Biotechnologies Corp reported Total Revenue of $276.98 million for fiscal year 2025.
Adaptive Biotechnologies Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $276.98M | +54.8% |
| 2024 | $178.96M | +5.1% |
| 2023 | $170.28M | -8.1% |
| 2022 | $185.31M | +20.1% |
| 2021 | $154.34M | +56.9% |
| 2020 | $98.38M | +15.6% |
| 2019 | $85.07M | +52.8% |
| 2018 | $55.66M | +44.8% |
| 2017 | $38.45M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $93.97M | +102.4% | +59.6% |
| June 30, 2025 | $58.88M | +36.3% | +12.3% |
| March 31, 2025 | $52.44M | +25.2% | +12.9% |
| September 30, 2024 | $46.44M | +22.5% | +7.5% |
| June 30, 2024 | $43.19M | -11.7% | +3.1% |
| March 31, 2024 | $41.87M | +11.2% | +10.4% |
| September 30, 2023 | $37.92M | -20.7% | -22.5% |
| June 30, 2023 | $48.93M | +12.1% | +30.0% |
- Adaptive Biotechnologies Corp showed an increase of +54.8% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Adaptive Biotechnologies Corp’s total revenue has grown by 620.4% (from $38.45 million to $276.98 million).
- The most recent figure is from Adaptive Biotechnologies Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: